For this purpose, 28 HPAH patients belonging to 18 different families were screened for BMPR2 mutations and/or rearrangements in order to identify BMPR2-negative samples to be tested for 12 additional candidate genes thanks to the development of a specific NGS panel. This evidence concerns the gene BMPR2 and heritable pulmonary arterial hypertension.